Insulinlike growth factor (IGF) I induces adipogenesis in vitro. IGF-binding protein 4 (IGFBP4) is highly expressed in adipocytes and osteoblasts and is inhibitory of IGFs in vitro. We previously reported that Igfbp4 null mice (Igfbp4 2/2 ) had decreased fat proportions at 8 and 16 weeks of age. However, the mechanism leading to the reduced adiposity remains unknown. The purpose of this study was to elucidate how IGFBP4 mediates adipose tissue development in vivo. Our results showed that inguinal and gonadal white adipose tissue (gWAT) from Igfbp4 2/2 mice had decreased weights and
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Pparg expression. Cultures of primary bone marrow stromal cells (BMSCs) and ear mesenchymal stem cells (eMSCs) from mutant mice showed reduced adipogenesis. Both BMSCs and eMSC had a strong induction of Igfbp4 expression during adipogenesis. Furthermore, the increase in phosphorylated Akt (p-Akt), a downstream target of IGF-I signaling, in wild-type cells, was blunted in mutant eMSCs. On a high-fat diet (HFD) there were sexual differences in adipocyte expansion of Igfbp4 2/2 mice. Mutant males gained weight by expanding their white fat depots. However,
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female mice gained weight in a manner similar to that seen in ovariectomized controls. Thus, Igfbp4 is required for inguinal fat expansion in female mice but not in male mice. However, gWAT expansion, which is prevented by estrogen during HFD, does not require Igfbp4. (Endocrinology 158: 3488-3500, 2017) I nsulinlike growth factor (IGF)-I is an important regulator of adipose tissue development in vivo (1, 2). However, its role in the pathogenesis of obesity is less clear. For example, IGF-I circulating levels were reported to be significantly higher in prepubertal obese children (3) , yet another study reported that obese patients had lower levels of growth hormone and hence less IGF-I (4, 5) . Furthermore, in an adipose-specific double-knockout of insulin and IGF receptors, mice had reduced adipose tissue and were protected against diet-induced obesity. However, they had more liver steatosis, suggesting that fat storage in the adipocytes was altered with loss of both insulin and IGF signaling (6) . Finally, it has been shown that IGF-I was expressed preferentially in the abdominal adipose depots rather than in inguinal fat in rats, suggesting a potential regulation of fat distribution by IGF-I (7). Thus, although it is apparent that IGF regulates fat development, the mechanism of action and the temporal sequence of such regulation remain unclear.
It is well established that the various actions of IGF are regulated by IGF-binding proteins(IGFBPs) in a tissuespecific manner. For example, Igfbp4 is highly expressed in adipocytes (8) . When subcutaneous fat explants were treated with growth hormone, the levels of IGF-I, IGF-II, and notably IGFBP4 were increased in the media (9) . Furthermore, a recent study showed that IGFBP4 partially regulated expansion of adipose tissue with excess calorie feeding (10) . Finally, a recent clinical report showed that IGFBP4 was produced in high quantity by adipose tissue and was cleaved by pregnancy-associated plasma protein A (PAPP-A) in visceral rather than subcutaneous fat depots (8) . Therefore, it is likely that IGFBP4 is a key regulator of adipose tissue development and maintenance.
In the current study, we postulated that adipocyte function might be altered in mice with deletion of Igfbp4. We previously published that Igfbp4 2/2 mice had retarded growth with significantly decreased fat proportions at 8 and 16 weeks of age that appeared independent from changes in IGF-I and IGFBP circulating levels (11) . Therefore, we decided to use this mouse model to address our hypothesis. We started by investigating the body composition phenotype of Igfbp4 2/2 mice and their capacity to expand their white adipose tissues. Our results indicate that Igfbp4 is required for adipogenesis and IGF signaling in adipocytes. Although both male and female mice adipose depots were decreased with loss of Igfbp4, conditions of white fat expansion revealed a sexual dimorphism in Igfbp4 2/2 mice. Indeed, mutant females were protected against diet-induced obesity whereas males were capable of gaining weight. We showed that the site of fat accumulation is tissue specific in male and females and that estrogen can control this specificity by regulating Igfbp4 expression. We also showed that Igfbp4 is important for adipocyte function in vivo and that it plays a role in the sex-specific distribution of fat both subcutaneously and viscerally.
Materials and Methods

Animals
Igfbp4 knockout mice (Igfpb4 2/2 ) were obtained from Dr. Brooks at Maine Medical Center Research Institute and originate from a Knockout Mouse Project allele project at University of California Davis. They were generated on the C57BL/6J background by deleting exon 2 of Igfbp4, which results in the global loss of IGFBP4. Genotyping strategy consisted in polymerase chain reactions using primer sets for the wild-type allele (forward: GGTAAACTGGCTCGGATTAGGG; reverse: TTGACTGTAGCGGCTGATGTTG) or the null allele (forward: TTGACTGTAGCGGCTGATGTTG; reverse: TGCCA-CAGTACCTCCCTTCTC) to distinguish between Igfbp4 
Metabolic phenotyping
To measure metabolic parameters, mice were placed in the Promethion Metabolic Cage System (Sable Systems, Las Vegas, NV) located in the Physiology Core Department of Maine Medical Research Institute. Data acquisition and instrument control were performed by using MetaScreen software, version 2.2.18, and the obtained raw data were processed by using ExpeData, version 1.8.2 (Sable Systems), with an analysis script detailing all aspects of data transformation. Mice were subjected to a standard 12-hour light/dark cycle during the study, which consisted of a 24-hour acclimation period followed by a 72-hour sampling duration, as previously described (12) . Data shown are representative of the 24-hour average of this period. Analysis of covariance analysis was performed between energy expenditure and lean, fat, and total body mass to determine whether these variables could explain changes in energy expenditure (EE). Significant correlations were found between EE and lean mass; thus, the adjusted EE is reported here.
Cell culture
Cells were isolated from mice and cultured in vitro to evaluate adipogenesis. Cells were cultured in a sterile waterjacketed CO 2 incubator (NU8700; NuAire, Plymouth, MN) at 37°C with 5% CO 2 . All the cell culture media, fetal bovine serum (FBS) and penicillin/streptomycin (P/S) were purchased from Gibco™ (Thermo Fisher Scientific, Waltham, MA).
Bone marrow stromal cells (BMSCs) were isolated from femurs and tibias from 8-week-old mice. After the bones were harvested and sectioned at their distal end, the bone marrow contents were spun out by centrifuging at 13,000g for 1 minute. Cell pellets were resuspended in culture media composed of minimal essential medium a with 10% FBS and 1% P/S. Cells were plated in six-well plates at 1,000,000 cells/cm 2 . Culture media were replenished every other day. Once cultures were confluent, cells were used for the adipogenesis assay.
Primary stromal vascular fraction cells (SVFs) were isolated from the inguinal adipose depots of 3-week-old mice. The fat pads were thinly cut in an isolation buffer composed of 123 mM NaCl, 1.3 mM CaCl 2 , 5 mM glucose, 4% bovine serum albumin, 100 mM HEPES, and 0.1% collagenase P in distilled sterile water. The samples were incubated for 1 hour at 37°C on a shaker before being filtered through a 70-mm filter. The filtered samples were centrifuged at 1200 rpm for 5 minutes at 4°C. Supernatant was removed and the cell pellet was washed with phosphate-buffered saline (PBS). The cell solution was centrifuged again and the resulting pellets were resuspended in SVF culture media composed of Dulbecco's modified Eagle medium (DMEM) supplemented with 20% FBS and 1% P/S. Cells were plated in six-well plates at 500,000 cells/cm 2 . Primary ear mesenchymal stem cells (eMSCs) were isolated from the outer ears of 3-week-old mice as previously described (13) . Briefly, outer ears were finely chopped in PBS containing 2 mg/mL of collagenase I (Worthington Biochemical ® , Lakewood, NJ). Samples were incubated for 1 hour at 37°C on a shaker before being passed through a 70-mm filter. DMEM/F12 was added to the samples to quench the Collagenase I. Samples were centrifuged at 596g for 10 minutes at 28°C and the supernatants were removed. Pellets were resuspended in Red Blood Cell Lysis Buffer (Sigma-Aldrich, St. Louis, MO) and incubated for 1 minute at room temperature. DMEM/F12 was added to the samples to quench the Red Blood Cell Lysis Buffer before they were centrifuged at 596g for 10 minutes at 28°C. Supernatants were discarded and pellets were resuspended in cell culture media composed of DMEM/F12 supplemented with 15% FBS and 10 mg/mL Primocin (InvivoGen). Cells were plated at 500,000 cells/cm 2 . Adipogenesis was induced in confluent cultures by switching to DMEM high-glucose media containing 2 mM insulin, 0.5 mM 3-isobutyl-1-methylxanthine, 1 nM dexamethasone, and 20 nM rosiglitazone. After 48 hours, eMSC were switched to media containing 0.1mM insulin and 80 mM rosiglitazone. After 96 hours, BMSCs were switched to media containing 2 mM insulin and 20 nM rosiglitazone. A week after adipogenesis induction, cells were fixed by using 10% neutral buffered formalin for 1 hour at room temperature. Cells were washed with PBS and 60% isopropanol in water and stained with a filtered 3.5 mg/mL solution of Oil Red-O in 60% isopropanol for 15 minutes. Cells were washed twice with water before microscopy analysis. Oil Red-O concentration was measured by adding 1 mL of isopropanol to each well and reading the absorbance at 560 nm of each sample and of standards.
Western immunoblots
Proteins from cell culture were extracted by scraping the culture wells in presence of a protein lysis buffer composed of 70 mM Tris-HCl, pH 6.8, 4 M glycerol, and 2% sodium dodecyl sulfate. Protein quantity was estimated by using the DC™ Protein Assay kit (BioRad, Hercules, CA) according to the manufacturer's guidelines. Twenty micrograms of protein was resolved on Mini-PROTEAN ® TGX™ Precast Gels (BioRad) before being transferred on a polyvinylidene fluoride membrane (BioRad). The membrane was incubated in blocking media consisting of 5% nonfat dry milk in tris-buffered saline/Tween 20 for 1 hour (10 mM Tris-HCl, 150 mM NaCl, 0.1% Tween 20 in water) and incubated in primary antibody overnight at 4°C diluted 1:1000 in blocking media. The membrane was washed in tris-buffered saline/Tween 20 and incubated in secondary antibody diluted 1:5000 in blocking media for 1 hour. Horseradish peroxidase substrate was SuperSignal™ West Dura Extended Duration Substrate (Thermo Fisher Scientific). Akt (#9272) and p-Akt (#736E11) antibodies were purchased from Cell Signaling (Danvers, MA). Secondary horseradish peroxidase-conjugated anti-rabbit (NA934) antibody was purchased from GE Healthcare BioSciences (Marlborough, MA).
Gene expression analysis
Total RNA was isolated from flash-frozen adipose tissues of 16-week-old mice using the TRIzol (Life Technologies, Grand Island, NY) method for tissues. Briefly, frozen samples were crushed and placed in TRIzol. Samples were centrifuged for 10 minutes at 5000g at 4°C to separate the fat from the cell contents. The upper flat layer was removed before chloroform was added to the TRIzol samples. Samples were centrifuged for 15 minutes at 10,000g at 4°C to separate the phenol phase and the phase containing the RNA. RNA was then precipitated from the samples using isopropanol. RNA concentrations were estimated by using NanoDrop 2000 (Thermo Fisher Scientific) and 500 ng RNA was used as template for the reverse transcription reaction into complementary DNA using the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific). The complementary DNA was diluted 1:20 in nanopure water before being used for quantitative polymerase chain reaction. The iQ SYBR Green Supermix and iQ5 thermal cycler detection system (BioRad) were used to quantify RNA expression. A GeNorm kit was used to find the most stable housekeeping gene for adipose tissue, which was determined as b-Actin. Primers for the housekeeping gene and the genes of interested were purchased from PrimerDesign (Southampton, United Kingdom) and designed to be 95% to 100% efficient. Sequences were as follows: b-Actin, sense: CTGTCCCTGTAT-GCCTCTG, antisense: ATGTCACGCACGATTTCC; Igfbp4, sense: TACCCACGAAGACCTCTTCATC, antisense: GTCTTC-CGATCCACACACCA; Pparg, sense: TGCGGAGACACA-GATGAAGA, antisense: TTGCCAAGAGAGTCGCTTTG; Ucp1, sense: GGTAAAAACAAGATTCATCAACTCTC, antisense: TCGCAGAAAAGAAGCCACAA.
Dual-energy X-ray absorptiometry
Dual-energy X-ray absorptiometry (DXA) was performed on 16-week-old animals to assess body composition by measuring fat and lean masses after the diet challenge, as previously published (14) . Measurements were taken, with exclusion of the head, by using the PIXImus densitometer (GE-Lunar, Fairfield, CT). A phantom standard provided by the manufacturer was used for instrument calibration before each measurement.
Histology
Tissues for histology were harvested from 16-week-old animals (n = 6 to 8 per group) and fixed in 10% neutral buffered formalin for up to a week before being processed for embedding in paraffin. Tissue samples were dehydrated by using a gradient of ethanol before being submerged in xylene. Tissues were then embedded in paraffin. Five-micrometer sections were cut by using a microtome and placed onto histologic slides. Hematoxylin-eosin staining was performed on adipose tissue sections to examine cellular structure. Three pictures per slide of random nonoverlapping fields were taken under 203 magnification. Pictures were loaded onto BIOQUANT ® OSTEO software (Bioquant, Nashville, TN) to assess adipocyte size.
Oil Red-O staining was performed on frozen sections of liver. Liver samples were placed in a 30% sucrose solution in PBS at 4°C overnight before being placed in optimal cutting temperature media from Tissue-Tek ® (Sakura) and frozen in liquid nitrogen. Samples were stored at 280°C before sectioning was performed to obtain 5-mm sections.
Statistical analysis
All data are expressed as the mean 6 standard error of the mean. Results were analyzed for statistically significant differences by using a Student t test or a two-way analysis of variance followed by Bonferroni multiple comparison post hoc tests. All statistics, including covariate analyses, were performed with Prism 6 statistical software (GraphPad Software, Inc., La Jolla, CA). Statistical significance was set at P , 0.05.
For mice cohorts, we powered (b = 0.95) the study for n = 8 mice per experimental group for DXA and tissue collection to complete all assays with a standard deviation of 1% in the DXA measurement tool for an a (p value) , 0.01). However, breeding and survival were limiting factors. Numbers of mice used in specific experiments are indicated in each figure.
Results
Decreased adiposity in Igfbp4
2/2 mice
Inguinal white adipose tissue (iWAT) and gonadal white adipose tissue (gWAT), as well as interscapular brown adipose tissue (BAT), were isolated from 16-weekold animals. White adipose tissues from Igfbp4 2/2 mice were significantly smaller than controls. However, BAT did not appear affected with loss of Igfbp4 in male or female mice (Fig. 1) .
To understand whether the decreased adiposity of the mutant mice was due to metabolic alterations, 12-weekold animals were placed in the metabolic cages to measure their food intake, EE, activity, and respiratory quotient. Groups did not differ in daily calories consumed (Supplemental Fig. 1A ) or in grams of food consumed per gram of body weight (Supplemental Fig. 1B) . When EE was adjusted by lean mass, which was a significant covariate, we observed a modest but significant increase in Igfbp4 2/2 male mice compared with controls. The female mice, however, did not differ from their littermate controls (Supplemental Fig. 1C ). There was no remarkable difference in wheel activity or respiratory quotient in the mutant mice (Supplemental Fig. 1D and 1E ). Next, we investigated gene expression in the adipose tissues of Igfbp4 2/2 and their control littermates to examine whether adipogenic-relevant genes might be altered. Igf1r and Igf1 expressions were not significantly changed in iWAT or gWAT of mutant mice when compared with their sex-matched littermate controls (data not shown). However, Pparg expression was significantly downregulated in iWAT, gWAT, and BAT of female mutant mice (Supplemental Fig. 2A) . Similarly, Igfbp4 2/2 males showed a decrease of Pparg expression in iWAT and BAT; however, expression remained unchanged in gWAT (Supplemental Fig. 2B ). Interestingly, Pgc1a expression was similar to that of controls in the white adipose depots of female and in male mutant mice (Supplemental Fig. 2A and 2B) . We observed no difference in the expression of Ucp1 in male or female mice with deletion of Igfbp4 (Supplemental Fig. 2A and 2B ). BMSC adipogenesis assays revealed a significant decrease of adipogenesis in cells isolated from both male and female mutants when compared with control cells (Fig. 2A) . eMSC (Fig. 2B ) and SVF ( Figure Fig. 2C ) cultures followed the same pattern of diminished adipogenesis with significant reductions of Oil Red-O staining. Interestingly, BMSCs and eMSCs isolated from control mice rapidly upregulated their expression of Igfbp4 upon differentiation (Supplemental Fig. 3A) . We observed a 15-fold increase of RNA expression for Igfbp4 after day 2 of differentiation that was maintained until day 8 of adipogenesis (Supplemental Fig. 3B ), indicating a potential local mechanism of IGF regulation in early differentiating adipocytes. To determine whether IGF downstream signaling was activated during adipogenesis, we examined the levels of phosphorylated Akt (p-Akt). p-Akt levels were increased from day 0 to day 8 of adipogenesis in eMSCs isolated from control mice. Although the same pattern was observed in differentiating cultures from Igfbp4 2/2 mice, it was blunted (Supplemental Fig. 3C ). (Fig. 3A) . Indeed, DXA analysis revealed that HFD-fed control mice significantly increased their fat mass, while mutant females did not (Fig. 3B) . Not unexpectedly, a mild but significant increase of lean mass was noted in control females fed with HFD compared with LFD controls, but this was not observed in Igfbp4 2/2 females (Fig. 3C) .
Decreased adipogenesis in progenitors from
Interestingly, mutant males did not respond to HFD in the same way as the mutant females. Indeed, HFD-fed Igfbp4 2/2 males showed a significant increase of body weight, as did their control littermates (Fig. 3D) . HFD challenge resulted in an increase of fat mass in both mutants and control males when compared with LFD-fed mice (Fig. 3E) . Unlike HFD-fed Igfbp4 +/+ females, control and mutant males did not increase their lean mass when challenged with HFD (Fig. 3F ). In sum, female mice appear to be protected against diet-induced obesity with loss of Igfbp4 whereas the males are not.
Excessive fat accumulates at different sites in female and male mice
To examine the adipocyte response after high-fat feeding, we performed histology on distinct white adipose tissues. Igfbp4 +/+ females showed significant increases in inguinal and gonadal adipocyte sizes with an HFD (Fig. 4A) . Although we noted a modest increase in gonadal adipocyte size in Igfbp4 2/2 females, the difference did not reach statistical significance. Indeed, there was no significant difference in inguinal or gonadal adipocyte size in Igfbp4 2/2 females fed LFD or HFD (Fig. 4A) . Concordant with their ability to gain weight with HFD challenge, Igfbp4 2/2 male inguinal and gonadal adipocytes showed expansion similar to that of adipocytes of Igfbp4 +/+ males (Fig. 4B) . We noted that the adipocyte size changed more in the inguinal depot than the gonadal depot in female control mice. However, in male mice, gonadal adipocytes enlarge more than do inguinal adipocytes.
To determine the site specificity of IGFBP-4 action in adipose depots, we calculated ratios of pad weights and adipocyte size for the white adipose tissues. Both iWAT and gWAT weights were increased with HFD in Igfbp4 +/+ female and male mice (Fig. 5A and 5C ). However, fat pad weight and adipocyte size were increased more in the inguinal depot than in the gonadal depot in Igfbp4 +/+ female mice (Fig. 5A and 5B)). Igfbp4 2/2 females had a significant increase in gWAT weight and a moderate increase in gonadal adipocyte size with an HFD; however, no changes were observed at the inguinal level ( Fig. 5A and 5B). In male mice, all depots and adipocyte size were expanded with a similar magnitude regardless of genotype ( Fig. 5C and 5D ). Our data are concordant with the previously published suggestion that female mice accumulate fat primarily in the inguinal depot (16) . To observe whether fat was accumulating in ectopic sites, we performed histology of the liver and interscapular BAT. Indeed, during conditions of high-fat feeding, accumulation of fat in BAT and in the liver has been reported (17, 18) . (A) BMSCs were isolated from 8-week-old mice, and (B) eMSCs and (C) SVFs were isolated from 3-week-old mice. Cells were differentiated into adipocytes for 7 days before being stained with Oil Red-O (ORO). ORO concentration was quantified and normalized to crystal violet absorbance. Experiments were performed in triplicate wells and repeated three times per adipogenesis assay. (* = t test P , 0.05; ** P , 0.01.) The error bars represent the standard error of the mean. Magnification 35 was used for all images.
fed with an HFD with accumulation of fat in their brown adipose tissue (Supplemental Fig. 4A ) and liver (Supplemental Fig. 4B ) as previously observed with the expansion of their white adipose tissues.
Igfbp4 regulation is sex and adipose tissue specific during HFD
To investigate whether the sexual discrepancy could be explained by differences in gene expression, we analyzed the RNA expression of Igfbp4 in male and female white adipose tissues. HFD challenge increased Igfbp4 expression significantly in iWAT in females (Fig. 6A) but not in males (Fig. 6B) . It remained unchanged in gWAT in both sexes (Fig. 6A and 6B) . Therefore, our results suggest that Igfbp4 is required for normal white adipose tissue function and also during conditions of calorie excess in female mice. However, Igfbp4 is regulated in a sex-specific manner as well as an adipose tissue-specific fashion.
The protective effect of Igfbp4
2/2 mice against fat expansion is caused by estrogen We hypothesized that the resistance to HFD-induced obesity specific to Igfbp4 2/2 females might be due to an estrogen-related mechanism. Thus, we performed ovariectomy on 8-week-old mice to abolish estrogen signaling. As previously reported in the literature, ovariectomized control and mutant mice gained a significant amount of body weight when compared with sham-operated mice (Fig. 7A) . Interestingly, once estrogen signaling was depleted, Igfbp4 2/2 mice were also capable of increasing their body weight (Fig. 7A) . We examined whether Igfbp4 was differentially regulated in white adipose tissue with loss of estrogen. Igfbp4 expression in iWAT did not change upon ovariectomy. Yet, there was a significant downregulation of Igfbp4 in gWAT with depletion of estrogen (Fig. 7B) . White adipose tissues were expanded with increased adipocyte size upon ovariectomy of both control and mutant mice (Fig. 7C) . Igfbp4 +/+ ovariectomized mice did not show alterations of their inguinal adipocyte size or iWAT weight (Fig. 7D ) when compared with sham-operated controls. However, adipocyte size and fat pad weight at the gonadal level significantly increased in Igfbp4 +/+ ovariectomized mice (Fig. 7D) . Intriguingly, Igfbp4 2/2 ovariectomized mice had a significant increase of weight in both iWAT and gWAT; however, the gonadal expansion was more robust than the inguinal one (Fig. 7D ).
Discussion
In this study, we postulated that Igfbp4 was required for adipogenesis. Our hypothesis stemmed from our previously published results on the body composition of the Igfbp4 2/2 mice (11). Indeed, we observed a marked decrease of fat proportion in Igfbp4 2/2 male and female mice at both 8 and 16 weeks of age when compared with littermate controls. Surprisingly, the decreased growth observed in our mutant mice was independent from IGF-I and other IGFBP circulating levels but rather was the result of tissue-specific regulation of IGF-I signaling by IGFBP4 (11). IGF-I and growth hormone (GH) have long been known to be important regulators of adipocyte differentiation and metabolism. Early clinical studies have shown that patients with GH deficiency tend to develop obesity with increased subcutaneous and visceral fat, and GH treatment can reduce this increase in adiposity by changing adipocyte size and number (19, 20) . Another study showed that IGF-I treatment could decrease subcutaneous fat in patients with Laron syndrome by acting directly on adipose tissue (21) . On the other hand, IGF-I is a known inducer of adipogenesis. Therefore, because Igfbp4 is highly expressed in adipose tissue, we postulated that there must be a cell-autonomous effect of IGFBP4 on adipocytes that worked independently of IGF-I or to modulate IGF-I actions. To shed light on this Figure 4 . Fat distribution is depot and sex-specific after HFD. Representative images of hematoxylin-eosin sections of iWAT and gWAT harvested from (A) female and (B) male mice after 8 weeks of LFD or HFD. Adipocyte sizes for the inguinal and gonadal depot were assessed by using BIOQUANT software and reported under their respective panels. (n = 6/genotype/sex/diet group. *Two-way analysis of variance multiple comparison P , 0.05; ** P , 0.01.) The error bars represent the standard error of the mean.
potential mechanism, we investigated the adipose phenotype of Igfbp4 2/2 mice and subjected them to two models of white fat expansion: HFD challenge and ovariectomyinduced weight gain. Inguinal and gonadal fat pads were reduced in both male and female Igfbp4 2/2 mice when compared with Igfbp4 +/+ mice ( Fig. 1) , consistent with our previous DXA analyses. Furthermore, EE was higher in mutant males than in controls (Supplemental Fig. 1 ). Thus, a metabolic mechanism of increased EE in Igfbp4 2/2 males may contribute to their decreased adiposity. Interestingly, EE is not altered in Igfbp4 2/2 female mice, suggesting that this potential mechanism is male specific. Indeed, the gene expression analysis revealed sexspecific alterations in white adipose tissue. Whereas Pparg expression was markedly downregulated in iWAT and gWAT of Igfbp4 2/2 female mice, it was decreased only in iWAT but not in gWAT in Igfbp4 2/2 male mice (Supplemental Fig. 2B ). Yet, gonadal fat pads were significantly smaller in Igfbp4 2/2 male mice than controls (Fig. 1) . Therefore, it appears that the mechanism involved in the alteration of white adipose tissue development is distinct in males and females and appears to be specific to subcutaneous or gonadal fat.
The adiposity phenotype related to IGFBP-4 appears to be specific to white adipose tissue. Indeed, despite a remarkable decrease of Pparg expression in BAT, Ucp1 expression was not altered (Supplemental Fig. 2 ) and the weight of BAT did not appear to be altered with loss of Igfbp4 (Fig. 1) . This suggests that Igfbp4 might not be critical for brown fat development than it is for white adipose tissue and thermogenic function is not likely to be altered in the mutant mouse. Supporting this hypothesis, the expression of Pgc1a, a gene involved in the metabolic activity of adipocyte (22, 23) , was not altered in the white adipose tissue of female and male Igfbp4 2/2 mice (Supplemental Fig. 2 ).
The decrease in adiposity and Pparg expression observed in Igfbp4 2/2 mice led us to investigate a potential adipogenesis defect. We observed a marked decrease of adipocyte differentiation observed in BMSCs, eMSCS, and SVFs (Fig. 3) of Igfbp4 2/2 mice; similarly, there was a robust upregulation of Igfbp4 expression throughout adipogenesis in wild-type cells (Supplemental Fig. 3A and 3B]. Thus, Igfbp4 appears to be critical for adipogenesis, consistent with its early expression pattern, and is also found in mature adipocytes. We initially hypothesized that cells from Igfbp4
mice would have increased adipogenesis and increased IGF signaling because IGFBP4 is known to act as an inhibitor of IGF in vitro. In addition, the increase of p-Akt (Supplemental Fig. 3C ) during adipogenesis suggested that induction of IGF signaling was important for differentiating adipocytes. However, on the basis of our current data, we propose that IGFBP4 acts as local reservoir for IGF, as Miyakoshi et al. previously suggested after they noticed that systemic injections of IGFBP4 could induce bone formation by increasing IGF bioavailability (24) . This would also explain why the phosphorylation of Akt was blunted in cell cultures from mutant mice Fig. 4C ). Thus, local loss of IGFBP4 in adipose tissue might result in decreased IGF signaling and therefore decreased adiposity in Igfbp4 2/2 mice.
Because IGF-I is also important in the pathogenesis of obesity, we also hypothesized that white fat hypertrophy was altered in Igfbp4 2/2 mice with excess calorie consumption. Indeed, it was previously reported that although Igfbp4 is expressed in differentiating adipocytes, its expression is decreased in adipose tissue with an HFD (10). Igfbp4 2/2 female mice were not capable of gaining weight like their Igfbp4 +/+ littermates with an HFD (Fig. 3A-3C) suggesting that Igfbp4 is not solely important for adipocyte differentiation but also fat expansion in females. In support of this, Igfbp4 2/2 female mice did not show HFD-induced adipocyte hypertrophy (Fig. 4A ) and were protected against ectopic fat accumulation in BAT and liver (Supplemental Fig. 4) . Therefore, deletion of Igfbp4 impairs the ability to accumulate lipid in females even during excessive calorie consumption. HFD challenge revealed an intriguing sex-specific adipose expansion of the Igfbp4 2/2 mice. Indeed, mutant male mice were capable of gaining a significant amount of weight ( Fig. 3D-3F ) because of the hypertrophy of their white adipocytes (Fig. 4B) . Previous studies showed that male mice are capable of expanding their white adipose tissue storage at the gonadal level with adipocyte hypertrophy (16) and increased angiogenesis (25) . This, in combination with our results indicating that Igfbp4 is not required for gonadal fat expansion (Fig. 6B) , could explain why mutant male mice can gain weight as well as their littermate controls do. Interestingly, we noted that the adipocyte hypertrophy in Igfbp4 +/+ female mice was more important in the inguinal depot than in the gonadal depot ( Fig. 5A and 5B) while it was of similar amplitude in the depots of male mice ( Fig. 5C and 5D) . A compelling body of evidence demonstrates that female and male mice accumulate fat differently in conditions of excessive dietary intake (26, 27) . Indeed, in conditions of excessive fat intake, female rats use the inguinal depot as the primary site for storage (28) . Thus, in conditions of excessive dietary fat in females, inguinal appears to be the first target of storage. Another recent study showed that the gonadal and inguinal adipose depots were storing excess fat differentially in male and female mice (16) . IGFs are known to play a role in this depot-specific regulation. It was shown that IGF-1 activation of Akt was decreased in abdominal adipocytes compared with subcutaneous adipocytes (29) . Consequently, IGF signaling might be more important in inguinal adipose tissue development. We suggest that Igfbp4 participates similarly in this site-specific distribution of fat observed in females. Indeed, gene expression analysis revealed that Igfbp4 was significantly upregulated at the inguinal level but not in the gonadal depot with HFD in female mice. Therefore, female mice lacking Igfbp4 in their inguinal depot are incapable of increasing their inguinal storage capacity, possibly because of an alteration of IGF signaling at the tissue level. At the gonadal level, however, IGF signaling is less important and other mechanisms might protect against gonadal fat accumulation.
One potential mechanism might be related to the protective actions of estrogen. For example, absence of a body composition phenotype in male mutant mice suggests that these mice are capable of increasing both their inguinal and their gonadal fat storage. To test this, ovariectomy was performed on mice to deplete estrogen. With ovariectomy, both Igfbp4 +/+ and Igfbp4 2/2 mice gained a significant amount of weight (Fig. 7A) . However, as opposed to an HFD, ovariectomy induced fat expansion primarily at the gonadal level (Fig. 7D) . Indeed, the size of adipocytes and the weight of the inguinal depot decreased only modestly with ovariectomy. We noticed that the increased fold change of the inguinal fat pad weight reached statistical significance in Igfbp4 2/2 female mice but not in control mice. This is likely due to the fact that the weights of the fat pads of the mutant mice are decreased compared with those of the controls in normal conditions; therefore, the fold changes appeared greater in mutants after ovariectomy. Moreover, we noted a marked decrease in Igfbp4 expression in gonadal but not inguinal fat in ovariectomized control mice ( Figure Fig. 7B ). Therefore, it appears that estrogen induces Igfbp4 expression in gWAT. With ovariectomy, its expression needs to be blunted for gWAT expansion. This would also explain why Igfbp4 2/2 females are still capable of moderately increasing their gWAT weights with an HFD (Fig. 5A) . Thus, we suggest that estrogen prevents gonadal white adipose tissue expansion in conditions of excessive fat intake, resulting in inguinal fat accumulation. When estrogen is depleted, Igfbp4 expression is reduced in gWAT and the expansion can occur. This mechanism is concordant with a recent clinical study showing that cleavage of IGFBP4 by PAPP-A was higher in visceral fat than in subcutaneous fat of obese women (8) . This is also consistent with observations from Conover et al. (15) , who showed that visceral fat did not expand in PAPP-A knockout mice during an HFD, indicating that IGFBP4 needs to be cleaved for visceral fat to expand. In summary, although loss of Igfbp4 affects adipose tissue development similarly in males and females, there is a clear sex dimorphism during fat expansion. The decreased adipogenesis occurring with deletion of Igfbp4 explains the reduction in adiposity observed in both male and female mutant mice. However, only Igfbp4 2/2 male adipocytes remain capable of accumulating fat in conditions of excessive fat intake. The protective effect against fat expansion observed in female mice is caused by estrogen. Indeed, Igfbp4 appears to be playing a role in the specific fat distribution regulated by estrogen in female mice. Understanding what mechanisms regulate fat distribution is important in the fight against obesity because subcutaneous fat is known to be more insulin sensitive and less metabolically hazardous than visceral white adipose tissue. Our data on IGFBP4 emphasizes the importance of local regulation of IGF signaling on adipose tissue and the difference of IGF signaling within subcutaneous and abdominal adipose depots. Elaborating the metabolism of Igfbp4 2/2 mice could also shed light on their sex-specific resistance to HFD-induced obesity.
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